LNSRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
LENSAR, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$5.75−0.05 (-0.86%)
Close on Oct 19, 2026
- Market cap
- $132.41M
- P/E (TTM)
- –
- Dividend yield
- –
LENSAR, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Product | $45.93M | $41.07M | $31.64M | $25.96M | $26.25M | $19.83M | $23.25M | 78.6% | +11.8% |
| Service | $5.73M | $4.90M | $4.07M | $3.48M | $3.25M | $2.95M | $3.09M | 9.8% | +17.0% |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| United States | $34.31M | $28.91M | $25.26M | $18.78M | $15.00M | $11.60M | $10.92M | 58.7% | +18.7% |
| Europe | $8.43M | $10.16M | $5.59M | $4.41M | $5.81M | $3.59M | $3.45M | 14.4% | -17.0% |
| Asia (Excluding South Korea) | $8.02M | $5.49M | $3.84M | $3.58M | $3.86M | $4.19M | $3.66M | 13.7% | +46.2% |
| South Korea | $658.00K | $848.00K | $257.00K | $2.18M | $4.38M | $3.08M | $7.88M | 1.1% | -22.4% |
| Other | $238.00K | $563.00K | $776.00K | $502.00K | $449.00K | $319.00K | $441.00K | 0.4% | -57.7% |
From the segment and revenue-disaggregation notes of Lensar's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.